Safety and efficacy of incobotulinumtoxinA as a potential treatment for poststroke spasticity

Andrea Santamato Physical Medicine and Rehabilitation Section, “OORR Hospital,” University of Foggia, Foggia, Italy Abstract: Spasticity is a common disabling symptom for several neurological conditions. Botulinum toxin type A injection represents the gold standard treatment fo...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autor principal:	Santamato A
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2016
Materias:	post stroke-spasticity botulinum toxin incobotulinumtoxinA onabotulinumtoxinA abobotulinumtoxinA Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/a46c4cff9f314e0cb8b6987eb9ab881e
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:a46c4cff9f314e0cb8b6987eb9ab881e
record_format	dspace
spelling	oai:doaj.org-article:a46c4cff9f314e0cb8b6987eb9ab881e2021-12-02T06:31:47ZSafety and efficacy of incobotulinumtoxinA as a potential treatment for poststroke spasticity1178-2021https://doaj.org/article/a46c4cff9f314e0cb8b6987eb9ab881e2016-01-01T00:00:00Zhttps://www.dovepress.com/safety-and-efficacy-of-incobotulinumtoxina-as-a-potential-treatment-fo-peer-reviewed-article-NDThttps://doaj.org/toc/1178-2021Andrea Santamato Physical Medicine and Rehabilitation Section, “OORR Hospital,” University of Foggia, Foggia, Italy Abstract: Spasticity is a common disabling symptom for several neurological conditions. Botulinum toxin type A injection represents the gold standard treatment for focal spasticity after stroke showing efficacy, reversibility, and low prevalence of complications. In recent years, incobotulinumtoxinA, a new Botulinum toxin type A free of complexing proteins, has been used for treating several movement disorders with safety and efficacy. IncobotulinumtoxinA is currently approved for treating spasticity of the upper limb in stroke survivors, even if several studies described the use also in lower limb muscles. In the present review article, we examine the safety and effectiveness of incobotulinumtoxinA for the treatment of spasticity after stroke. Keywords: Hypertone, botulinum toxin, incobotulinumtoxinA, onabotulinumtoxinA, abobotulinumtoxinASantamato ADove Medical Pressarticlepost stroke-spasticitybotulinum toxinincobotulinumtoxinAonabotulinumtoxinAabobotulinumtoxinANeurosciences. Biological psychiatry. NeuropsychiatryRC321-571Neurology. Diseases of the nervous systemRC346-429ENNeuropsychiatric Disease and Treatment, Vol 2016, Iss Issue 1, Pp 251-263 (2016)
institution	DOAJ
collection	DOAJ
language	EN
topic	post stroke-spasticity botulinum toxin incobotulinumtoxinA onabotulinumtoxinA abobotulinumtoxinA Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
spellingShingle	post stroke-spasticity botulinum toxin incobotulinumtoxinA onabotulinumtoxinA abobotulinumtoxinA Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429 Santamato A Safety and efficacy of incobotulinumtoxinA as a potential treatment for poststroke spasticity
description	Andrea Santamato Physical Medicine and Rehabilitation Section, “OORR Hospital,” University of Foggia, Foggia, Italy Abstract: Spasticity is a common disabling symptom for several neurological conditions. Botulinum toxin type A injection represents the gold standard treatment for focal spasticity after stroke showing efficacy, reversibility, and low prevalence of complications. In recent years, incobotulinumtoxinA, a new Botulinum toxin type A free of complexing proteins, has been used for treating several movement disorders with safety and efficacy. IncobotulinumtoxinA is currently approved for treating spasticity of the upper limb in stroke survivors, even if several studies described the use also in lower limb muscles. In the present review article, we examine the safety and effectiveness of incobotulinumtoxinA for the treatment of spasticity after stroke. Keywords: Hypertone, botulinum toxin, incobotulinumtoxinA, onabotulinumtoxinA, abobotulinumtoxinA
format	article
author	Santamato A
author_facet	Santamato A
author_sort	Santamato A
title	Safety and efficacy of incobotulinumtoxinA as a potential treatment for poststroke spasticity
title_short	Safety and efficacy of incobotulinumtoxinA as a potential treatment for poststroke spasticity
title_full	Safety and efficacy of incobotulinumtoxinA as a potential treatment for poststroke spasticity
title_fullStr	Safety and efficacy of incobotulinumtoxinA as a potential treatment for poststroke spasticity
title_full_unstemmed	Safety and efficacy of incobotulinumtoxinA as a potential treatment for poststroke spasticity
title_sort	safety and efficacy of incobotulinumtoxina as a potential treatment for poststroke spasticity
publisher	Dove Medical Press
publishDate	2016
url	https://doaj.org/article/a46c4cff9f314e0cb8b6987eb9ab881e
work_keys_str_mv	AT santamatoa safetyandefficacyofincobotulinumtoxinaasapotentialtreatmentforpoststrokespasticity
_version_	1718399892731199488

Safety and efficacy of incobotulinumtoxinA as a potential treatment for poststroke spasticity

Ejemplares similares